Filing Details

Accession Number:
0001764013-24-000085
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-26 17:18:36
Reporting Period:
2024-04-24
Accepted Time:
2024-04-26 17:18:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1764013 Immunovant Inc. IMVT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1617236 S. Mark Levine C/O Immunovant, Inc.
320 W 37Th Street, 6Th Floor
New York NY 10018
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-04-24 3,963 $28.90 343,156 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. On January 28, 2022, the holder was granted 143,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on January 31, 2022, of which 8,937 of these RSUs vested on April 19, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.